CAS: 541-64-0; 1-(Furan-2-yl)-N,N,N-Trimethylmethanaminium Iodide

⚠️《化妆品禁用原料目录》
英文名称1-(Furan-2-yl)-N,N,N-Trimethylmethanaminium Iodide
中文名称呋索碘铵
IUPAC名称1-(furan-2-yl)-N,N,N-trimethylmethanaminium iodide
其它别名2-Furanmethanaminium,N,N,N-trimethyl-, iodide (9CI); Ammonium, furfuryltrimethyl-, iodide (8CI); Furfuryltrimethylammonium iodide (6CI,7CI); (2-Furylmethyl)trimethylammoniumiodide; Furamon; Furamon iodide; Furanol; Furmethide; Furmethide iodide; Furthrethonium iodide; Furtrethonium iodide; Furtrimethonium iodide; Trimethylfurfurylammonium iodide
CAS编号541-64-0
MFCD编号:MFCD00867181
EINECS号:208-789-5
FDA UNII编号:1D064NLD7G
分子式:C8H14INO分子量:267.11
产品CID: 2494884
产品分类原料药 → 专科用药 → 眼科用药

相似结构搜索
产品信息参考;;;;
InChIKey: YKASHPSKFYVZRC-UHFFFAOYSA-M
InChI=1S/C8H14NO.HI/c1-9(2,3)7-8-5-4-6-10-8;/h4-6H,7H2,1-3H3;1H/q+1;/p-1
计算化学: 氢键受体数2.0氢键供体数0.0可旋转键数2.0

物理性质

熔点116-117° (Weilmuenster, Jordan); mp 118-120° (Khromov-Borisov)
沸点116-117° (Weilmuenster, Jordan); mp 118-120° (Khromov-Borisov)
闪点 °C
密度3>g/ cm3
PSA:13.14
LogP:-1.5102
储存条件-196°C

MSDS等安全信息

上下游产品

CAS号617-89-0 糠胺 | CAS号74-88-4 碘甲烷 | CAS号13714-86-8 5-甲基-2-糠腈 | CAS号14496-34-5 1-(呋喃-2-基)-N,N-二甲基甲胺 | CAS号623-17-6 乙酸糠酯

合成工艺路线路线简述

📜2-呋喃甲胺置于potassium Carbonate,碘甲烷体系中,化学反应生成呋索碘铵
参考文献:Chromow-Borisow Et Al.,Zhurnal Obshchei Khimii,1954,Vol. 24,P. 2056; Engl. Ausg. S. 2021
标题:Chromow-Borisow Et Al.,Zhurnal Obshchei Khimii,1954,Vol. 24,P. 2056; Engl. Ausg. S. 2021

海关参考信息

2921199090-其他无环单胺
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-9751877-B2
优先权日:2012-09-21
标题 :Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
发明人：PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; PATEL NANDINI CHATURBHAI; STIFF CORY MICHAEL; TRAN TUAN PHONG; KAUFFMAN GREGORY WAYNE; STEPAN ANTONIA FRIEDERIKE; VERHOEST PATRICK ROBERT
权利人:PFIZER
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:JP-2000507918-A
优先权日:1995-11-08
标题:Stereoselective synthesis of endothelin receptor antagonists

专利号:TW-201121888-A
优先权日:2009-12-18
标题 :Synthesis of mesoporous carbon/silica composites and mesoporous carbon material

专利号:CN-101979387-A
优先权日:2010-09-25
标题 :The method that dicarboxylic acid aluminum phenate catalyzes the synthesis of furan phenol

专利号:US-9550795-B2
优先权日:2011-08-31
标题:Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
发明人：BRODNEY MICHAEL AARON; BUTLER CHRISTOPHER RYAN; HELAL CHRISTOPHER JOHN; O'NEILL BRIAN THOMAS
权利人:BRODNEY MICHAEL AARON; BUTLER CHRISTOPHER RYAN; HELAL CHRISTOPHER JOHN; O'NEILL BRIAN THOMAS; PFIZER
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:WO-2012172449-A1
优先权日:2011-06-13
标题:Lactams as beta secretase inhibitors
发明人：BRODNEY MICHAEL AARON
权利人:PFIZER; BRODNEY MICHAEL AARON
摘要:Compound and pharmaceutically acceptable salts of the compound are disclosed, wherein the compound has the structure (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. The compound of formula I is useful as beta secretase inhibitor for use in the treatment of Alzheimer's and other neurodegenerative and/or neurological disorders.